A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Givinostat | CAS 497833-27-9 - Request Quote

Picture of Givinostat
SZ CAT No:SZ-G061001
CAS No
497833-27-9
Mol.F.
C24H27N3O4
Mol.Wt.
421.5
Inv. Status
In Stock
Rel. CAS No199657-29-9 (HCl salt) ; 732302-99-7 (hydrochloride hydrate)
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Givinostat is chemically (6-((Diethylamino)methyl)naphthalen-2-yl)methyl (4-(hydroxycarbamoyl)phenyl)carbamate. Givinostat is supplied with detailed characterization data compliant with regulatory guideline. Givinostat can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Givinostat.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 497833-27-9

Purchase 497833-27-9

Order 497833-27-9

Enquire 497833-27-9

price of 497833-27-9

497833-27-9 Supplier

497833-27-9 Manufacturer

497833-27-9 Exporter

buy high quality Givinostat

Purchase Givinostat

Givinostat suppliers

Givinostat manufacturers

Givinostat price

Order Givinostat

Enquire Givinostat

Givinostat cost

Givinostat Supplier

Givinostat Distributor

Givinostat for Method Validation

Givinostat Reference Standard

Givinostat for ANDA Filing

Givinostat for Forced Degradation Studies

Givinostat Identification Standards

Givinostat for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,